Evonik Industries (EVK) PT Set at €36.00 by Sanford C. Bernstein
A number of other analysts have also recently weighed in on the stock. JPMorgan Chase & Co. set a €25.00 ($29.76) price target on shares of Evonik Industries and gave the company a sell rating in a report on Tuesday, November 14th. Warburg Research set a €38.70 ($46.07) price objective on shares of Evonik Industries and gave the company a buy rating in a research report on Monday, December 4th. Goldman Sachs Group set a €29.00 ($34.52) price objective on shares of Evonik Industries and gave the company a neutral rating in a research report on Monday, November 6th. Commerzbank set a €39.00 ($46.43) price objective on shares of Evonik Industries and gave the company a buy rating in a research report on Thursday, November 9th. Finally, UBS Group set a €27.00 ($32.14) price objective on shares of Evonik Industries and gave the company a sell rating in a research report on Thursday, December 7th. Two equities research analysts have rated the stock with a sell rating, six have issued a hold rating and eleven have issued a buy rating to the company’s stock. The stock currently has a consensus rating of Hold and an average target price of €33.81 ($40.24).
Evonik Industries (FRA:EVK) traded up €0.02 ($0.02) during trading hours on Monday, reaching €31.89 ($37.96). The company had a trading volume of 2,020 shares. Evonik Industries has a twelve month low of €26.78 ($31.88) and a twelve month high of €32.97 ($39.25). The firm has a market cap of $14,890.00 and a price-to-earnings ratio of 20.31.
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemical quaternary derivatives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, animal nutrition, and healthcare sectors.
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.